文献速递前列腺增生与排尿功能障碍男科与性医学

微创手术治疗良性前列腺增生所致男性下尿路症状对射精功能的影响:系统综述

Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-02-14

本系统综述纳入47项研究,评估Rezum、前列腺动脉栓塞(PAE)、前列腺尿道提升术(PUL)和临时植入式镍钛装置(TIND)对下尿路症状及性/射精功能的影响。Rezum和PUL对射精功能影响极小,PAE和TIND证据有限。所有技术均安全可行并伴显著功能改善。

要点

  • Rezum对IPSS改善-47%至-56%,Qmax改善+39%至+87%,IIEF-5仅下降1%至3%。
  • PUL对IPSS改善-35%至-58.2%,Qmax改善+49.9%至+114.7%,对性功能有积极影响。
  • PAE功能结果鼓舞但性结局证据有限;TIND证据同样有限。

核心结论

  • Rezum、PAE、PUL和TIND是安全可行的技术,与显著的功能改善相关。
  • 现有数据提示Rezum和PUL对射精功能影响极小,但PAE和TIND后的证据仍有限。
  • 本综述为进一步研究奠定基础,旨在确定选择最佳uMIST候选者的标准,以根据特定患者和疾病因素定制管理。

研究设计与样本

  • 系统综述,遵循PRISMA指南(PROSPERO ID: CRD42023466515),检索MEDLINE、Embase和Web of Science数据库2000年1月至2022年10月的英语文献。
  • 纳入评估男性LUTS微创手术治疗后功能与射精功能影响的随机对照试验(RCT)、前瞻性研究及非比较或比较研究。
  • 共纳入47项研究:TIND 4项,Rezum 9项,PUL 13项,PAE 21项。
  • 偏倚风险评估:比较研究采用ROBINS-I工具,RCT采用RoB 2工具。

主要发现

  • 大多数研究基于前瞻性患者队列,被评为低偏倚风险。
  • Rezum研究显示IPSS显著改善(范围-47%至-56%),Qmax改善(范围+39%至+87%),根据IIEF-5评分对性功能影响极小(范围-1%至-3%)。
  • PUL对IPSS有积极影响(范围-35%至-58.2%),Qmax改善(范围+49.9%至+114.7%),对性功能有积极影响。
  • PAE显示鼓舞人心的功能结果,IPSS评分降低从-12.8%至63.3%,Qmax改善从+8%至114.9%,但关于PAE对性结局潜在影响的现有证据有限。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • PAE和TIND后的证据仍有限。
  • 本综述为进一步研究奠定基础,旨在确定选择最佳uMIST候选者的标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical treatments for lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) are affected by potentially bothersome side effects on sexual, and, above all, ejaculatory function. Several minimally invasive techniques have been proposed in the last years in order to overcome these consequences. Our aim is to summarize and evaluate the efficacy on LUTS relieve and the impact on sexual/ejaculatory function of Rezum, prostate artery embolization (PAE), implantation of a prostatic urethral lift (PUL) and the temporary implantable nitinol device (TIND). METHODS: A systematic review of the English-language literature was conducted using the MEDLINE, Embase, and Web of Science databases from January 2000 to October 2022, according to the PRISMA guidelines (PROSPERO ID: CRD42023466515). Randomized controlled trials (RCTs), prospective studies and non-comparative or comparative studies assessing the impact on functional and ejaculatory function after minimally invasive surgical therapies for Male LUTS were evaluated. Risk of bias assessment was performed according to the Risk of Bias in Non-Randomized Studies of Interventions (ROBINS-I) tool for comparative studies, and the revised Cochrane risk-of-bias tool for randomized trials (RoB 2) for RCTs. RESULTS: Overall, 47 studies were included (n = 4 for TIND; n = 9 for Rezum; n = 13 for PUL; n = 21 for PAE). Most studies relied on prospective patient cohorts and were rated as low risk of bias. Across studies assessing the efficacy of Rezum, a significant improvement in terms of IPSS (ranging from -47% to -56%) and Qmax (ranging from +39% to +87%) was reported. On the other hand, according to IIEF-5 score, Rezum had a minimal impact on sexual function (ranging from -1% to -3%). PUL showed a positive impact on IPSS (ranging from -35% to -58.2%) and Qmax (ranging from +49.9% to +114.7%) and sexual function. Finally, PAE showed encouraging functional results with IPSS score reducing from -12.8% to 63.3% and Qmax improving from +8% to 114.9% but the available evidence regarding the potential impact of PAE on sexual outcomes were limited. CONCLUSION: Rezum, PAE, PUL and TIND are safe and feasible techniques associated with a significant functional improvement. While available data suggest a minimal impact of Rezum and PUL on ejaculatory function, the evidence after PAE and TIND are still limited. Therefore, our review lays the foundation for further research aiming to identify the criteria to select best candidates for uMIST to tailor the management in light of specific patient- and disease- factors.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Gemma L, Pecoraro A, Sebastianelli A, et al. Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review. Prostate Cancer Prostatic Dis. 2024. PMID: 38355729. doi:10.1038/s41391-024-00795-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。